PMGC Holdings ELAB
NASDAQ ELAB
$3.51 -0.03 (-0.75%)
As of: Oct 1, 2026 · 9:43 AM EDT

PMGC Holdings (ELAB) Receivables - Other (2025)

Updated

PMGC Holdings (ELAB) reported Receivables - Other of $76,212 for Q2 2025, up 46.2% from the prior quarter.

Analysis

PMGC Holdings (ELAB) Receivables - Other (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 PMGC Holdings 1.73 Mn -46.63 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 76,212.00
Mar 31, 2025 52,140.00
API Access

PMGC Holdings Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ELAB&period=max&api_key=YOUR_API_KEY